Navigation Links
Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
Date:2/3/2009

HOPKINTON, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE), announced today that it has completed enrollment in the first stage of the Altropane Parkinson's or Essential Tremor (POET-2) Phase III clinical program. The objective of the first part of the program was to acquire the set of Altropane images which will be used to train expert readers for the Phase III registration portion of the program. The Altropane molecular imaging agent is being developed by Alseres to aid in the early diagnosis of Parkinsonian Syndromes (PS).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO )

There are 11 million people in the U.S. alone living with tremor disorders of which more than one million have been diagnosed with Parkinson's disease. These figures are expected to double by 2030. According to peer-reviewed publications, misdiagnosis rates for PS are reported as high as 35-50%. "Millions of people experiencing tremor symptoms currently have no objective means to determine whether or not they have Parkinson's Disease," Ray L. Watts, MD, John N. Whitaker Professor and Chairman of the Department of Neurology, University of Alabama at Birmingham stated. "There is a clear need to improve the process for earlier diagnosis of Parkinson's Disease which improves patient outcomes and their ability to take advantage of neuroprotective therapies as they become avai
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
5. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
6. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
7. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
(Date:7/6/2015)... 6, 2015   BioClinica®, Inc ., a ... announced that it has acquired a leading global ... Inc. (Medici).  The acquisition includes affiliates MediciGlobal ... also provides a lost-to-follow-up patient locate service ( ... with Medici, BioClinica will offer pharmaceutical ...
(Date:7/6/2015)... DUBLIN, Ohio , July 6, 2015 ... of The Harvard Drug Group (THDG). A distributor of generic ... and alternate care customers, THDG was owned by Court ... all-cash transaction using existing cash and new debt.  ... , The Harvard Drug Group had revenues of approximately ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3
... May 10th, 2007 - Antisense,Pharma, a German biopharmaceutical ... announced, that data from the,Phase IIb-study with AP ... 43rd Annual Meeting of the American Society of,Clinical ... Illinois,U.S.A, from June 1st - 5th. , In ...
... NICE Appraisal Committee concludes that alteplase is clinically,and ... 2007 – A new clinical appraisal,published by the ... the UK has recommended the use of alteplase,for ... based on,its clinical and cost effectiveness compared with ...
Cached Medicine Technology:2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 2Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 3Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 4Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 5
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the highest regarded provider ... Walk-In Urgent Care to offer on-site health screenings. These ultrasound screenings detect early ... affordable and accurate and run about an hour long with same day results. ...
(Date:7/6/2015)... ... , ... MD Now, the leading and fastest-growing urgent care provider in Florida, ... will serve residents and visitors in the Cutler Bay area, giving them convenient access ... location, the new facility will be the fourth to serve Miami-Dade County. Located at ...
(Date:7/6/2015)... ... ... Dr. Lawrence Green is now offering the newly FDA-approved Kybella injectable to ... method to dissolve fat cells and is the first of its kind to be ... commonly known as a double chin. Dr. Green participated in clinical trials for Kybella ...
(Date:7/6/2015)... ... ... The Path of Least Resistance: The Evolution of Capitalism and Politics in America ... the past 40 years. The book explores the evolution of the global economy and ... time capsule that chronicles the economic development of the United States — from its ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special (high ... of unlimited classes for just $65. Student ID is needed at registration. , Women's ... Lake Orion. , Women’s Excellence is the most comprehensive obstetric and ...
Breaking Medicine News(10 mins):Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
... finds some children are more vulnerable , WEDNESDAY, Aug. ... in children who are already genetically susceptible to the ... 3,000 asthmatic children. , According to a team at ... Los Angeles, prior research had spotted variations in ...
... mouse study, it prevented buildup of dangerous tau protein ... designed to combat a protein implicated in Alzheimer,s disease ... Abnormal tau protein accumulates into damaging tangles in the ... a team at the New York University Medical Center ...
... usefulness of secondary procedures , , TUESDAY, Aug. 21 (HealthDay ... as peritonitis may not automatically need to undergo more ... , In the United States, most surgeons choose to ... extra surgery, said Dr. David Flum, a gastrointestinal surgeon ...
... major study finds , , TUESDAY, Aug. 21 (HealthDay News) -- ... cancer and acrylamide, a substance found in many baked and ... subject conducted to date. , "The data are accumulating, and ... to be an important breast cancer risk factor," said study ...
... during the first few days after their birth. A ... the Journal of Human Lactation explores the reasons why ... what conclusions can be drawn from the research. , ... the Journal of Human Lactation, for the International Lactation ...
... experiments, it boosted drugs, killing power 6-fold , , TUESDAY, ... of cranberry juice might greatly boost an ovarian cancer ... In laboratory experiments, pre-treating ovarian tumor cells with the ... researchers say. , The study authors stressed that the ...
Cached Medicine News:Health News:Traffic Fumes Plus Genes Boosts Kids' Asthma Risk 2Health News:One Surgery Often Enough for Peritonitis 2Health News:Acrylamide Won't Raise Breast Cancer Risk 2Health News:Acrylamide Won't Raise Breast Cancer Risk 3Health News:Acrylamide Won't Raise Breast Cancer Risk 4Health News:Cranberry Could Juice Up Ovarian Cancer Treatment 2Health News:Cranberry Could Juice Up Ovarian Cancer Treatment 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: